Menu
GeneBe

rs372668179

Variant summary

Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM1PM5PP3_ModeratePP5

The NM_000237.3(LPL):​c.590G>A​(p.Arg197His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000173 in 1,614,002 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R197C) has been classified as Likely pathogenic.

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000018 ( 0 hom. )

Consequence

LPL
NM_000237.3 missense

Scores

6
10
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:2U:2

Conservation

PhyloP100: 2.08
Variant links:
Genes affected
LPL (HGNC:6677): (lipoprotein lipase) LPL encodes lipoprotein lipase, which is expressed in heart, muscle, and adipose tissue. LPL functions as a homodimer, and has the dual functions of triglyceride hydrolase and ligand/bridging factor for receptor-mediated lipoprotein uptake. Severe mutations that cause LPL deficiency result in type I hyperlipoproteinemia, while less extreme mutations in LPL are linked to many disorders of lipoprotein metabolism. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_pathogenic. Variant got 7 ACMG points.

PM1
In a hotspot region, there are 3 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 5 uncertain in NM_000237.3
PM5
Other missense variant is known to change same aminoacid residue: Variant chr8-19954167-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 1471786.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.863
PP5
Variant 8-19954168-G-A is Pathogenic according to our data. Variant chr8-19954168-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 521082.We mark this variant Likely_pathogenic, oryginal submissions are: {Pathogenic=2, Uncertain_significance=2}.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
LPLNM_000237.3 linkuse as main transcriptc.590G>A p.Arg197His missense_variant 5/10 ENST00000650287.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
LPLENST00000650287.1 linkuse as main transcriptc.590G>A p.Arg197His missense_variant 5/10 NM_000237.3 P1
LPLENST00000520959.5 linkuse as main transcript downstream_gene_variant 4

Frequencies

GnomAD3 genomes
AF:
0.0000131
AC:
2
AN:
152116
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000676
AC:
17
AN:
251436
Hom.:
0
AF XY:
0.0000294
AC XY:
4
AN XY:
135890
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000405
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000176
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000178
AC:
26
AN:
1461886
Hom.:
0
Cov.:
32
AF XY:
0.0000138
AC XY:
10
AN XY:
727246
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.000335
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000116
Gnomad4 FIN exome
AF:
0.0000374
Gnomad4 NFE exome
AF:
0.00000629
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000131
AC:
2
AN:
152116
Hom.:
0
Cov.:
32
AF XY:
0.0000135
AC XY:
1
AN XY:
74308
show subpopulations
Gnomad4 AFR
AF:
0.0000483
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000151
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.0000412
AC:
5

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:2Uncertain:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingInvitaeJan 24, 2024This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 197 of the LPL protein (p.Arg197His). This variant is present in population databases (rs372668179, gnomAD 0.04%). This missense change has been observed in individual(s) with clinical features of chylomicronemia (PMID: 25966443; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 521082). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt LPL protein function with a negative predictive value of 80%. This variant disrupts the p.Arg197 amino acid residue in LPL. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 12839295, 25966443). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
Cardiovascular phenotype Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingAmbry GeneticsAug 31, 2021The p.R197H pathogenic mutation (also known as c.590G>A), located in coding exon 5 of the LPL gene, results from a G to A substitution at nucleotide position 590. The arginine at codon 197 is replaced by histidine, an amino acid with highly similar properties. This alteration has been reported in individuals with familial chylomicronemia syndrome (FCS) who were homozygous for this alteration or compound heterozygous for an additional alteration in LPL (Rabacchi C et al. Atherosclerosis, 2015 Jul;241:79-86; Hu X et al. Gene, 2021 Feb;768:145310; Ambry internal data). Furthermore, individuals who were heterozygous for this alteration were identified to have hypertriglyceridemia without an additional alteration identified in LPL (Wright WT et al. Atherosclerosis, 2008 Jul;199:187-92; Surendran RP et al. J Intern Med, 2012 Aug;272:185-96). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. -
not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpDec 03, 2022Variant summary: LPL c.590G>A (p.Arg197His) results in a non-conservative amino acid change located in the Lipase/vitellogenin domain (IPR013818) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 6.8e-05 in 251436 control chromosomes (gnomAD). This frequency is not higher than estimated for a pathogenic variant in LPL causing Familial Lipoprotein Lipase Deficiency (0.0034), allowing no conclusion about variant significance. c.590G>A has been reported in the literature in at least two compound heterozygous individuals affected with severe hypertriglyceridaemia, who carried probably pathogenic missense variants in trans (example, Rabacchi_2015, Hu_2021), and was also reported in individuals with hypertriglyceridaemia a where a second variant was not specified (Wright_2008, Surendran_2012). It has recently been reported as a heterozygous genotype combined with a different heterozygous LMF1 gene variant (c.1523C>T, p.Pro508Leu) in a family Hypertriglyceridemia with authors suggesting that severe hyptertriglyceridemia was of digenic origin caused by LMF1 and LPL double heterozygosity (Guo_2022). These data indicate that the variant may be associated with disease. To our knowledge, no variant specific experimental evidence demonstrating an impact on protein function has been reported. A different variant affecting the same amino acid, c.590G>T (p.Arg197Leu), was reported in homozygous individuals affected with severe hypertriglyceridemia (Rabacchi_2015), suggesting that Arg197 could be important for protein function. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. One laboratory classified the variant as pathogenic, one as likely pathogenic and one as uncertain significance. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. -
Hyperlipidemia, familial combined, LPL related Uncertain:1
Uncertain significance, criteria provided, single submittercurationBroad Center for Mendelian Genomics, Broad Institute of MIT and HarvardJan 22, 2020The p.Arg197His variant in LPL has been reported in at least 3 individuals (including 1 individual from Northern Ireland and 1 individual from the Netherlands) with Familial Hyperlipidemia (PMID: 28267856, 22239554, 18068174, 25966443), and has been identified in 0.03951% (14/35438) of Latino chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs372668179). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a carrier frequency. Please note that for diseases with clinical variability, or reduced penetrance, pathogenic variants may be present at a low frequency in the general population. This variant has also been reported pathogenic in ClinVar (Variation ID: 521082). Computational prediction tools and conservation analyses do not provide strong support for or against an impact to the protein. Two missense variants (p.Arg197Leu and p.Arg197Cys) with a different amino acid change at the same position have been reported in association with disease in the literature (PMID: 25966443, 28267856). In summary, while there is some suspicion for a pathogenic role, the clinical significance of this variant is uncertain. ACMG/AMP Criteria applied: PM2_Supporting, PS4_Supporting, PM5_Supporting (Richards 2015). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.30
BayesDel_addAF
Uncertain
0.12
D
BayesDel_noAF
Pathogenic
0.26
CADD
Pathogenic
29
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.84
D;D
Eigen
Uncertain
0.66
Eigen_PC
Uncertain
0.63
FATHMM_MKL
Uncertain
0.94
D
M_CAP
Pathogenic
0.41
D
MetaRNN
Pathogenic
0.86
D;D
MetaSVM
Pathogenic
0.88
D
MutationAssessor
Uncertain
2.4
M;M
MutationTaster
Benign
0.89
D
PrimateAI
Uncertain
0.64
T
PROVEAN
Uncertain
-4.1
D;.
REVEL
Uncertain
0.62
Sift
Uncertain
0.0020
D;.
Sift4G
Uncertain
0.055
T;.
Polyphen
1.0
D;D
Vest4
0.85
MVP
0.97
MPC
0.49
ClinPred
0.88
D
GERP RS
6.2
Varity_R
0.75
gMVP
0.92

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs372668179; hg19: chr8-19811679; COSMIC: COSV60931786; COSMIC: COSV60931786; API